Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis. [electronic resource]
Producer: 20060929Description: 2271-81 p. digitalISSN:- 0090-3493
- Animals
- Antibodies -- blood
- Bronchoalveolar Lavage Fluid -- chemistry
- Double-Blind Method
- Female
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunologic Factors -- therapeutic use
- Infusions, Intravenous
- Intensive Care Units -- statistics & numerical data
- Interleukin-6 -- analysis
- Male
- Middle Aged
- Prospective Studies
- Respiration, Artificial -- statistics & numerical data
- Sepsis -- drug therapy
- Sheep -- immunology
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Comment
There are no comments on this title.
Log in to your account to post a comment.